SubHero Banner

Sohonos (palovarotene) – New orphan drug approval

August 16, 2023 - Ipsen announced the FDA approval of Sohonos (palovarotene), for the reduction in volume of new heterotopic ossification in adults and pediatric patients aged 8 years and older for females and 10 years and older for males with fibrodysplasia ossificans progressiva (FOP).

Download PDF